Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 6,666 | $62.00 | $413,292.00 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 6 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,580 F2 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 6,883 | $57.00 | $392,331.00 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 5 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,246 F2 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionCommon Stock | 4,906 | $19.12 | $93,802.72 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 4 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionCommon Stock | 8,124 | $22.12 | $179,702.88 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 3 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionCommon Stock | 3,336 | $22.70 | $75,720.53 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:03 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionCommon Stock | 2,030 | $27.76 | $56,352.80 |
DisclosureSEC source: 0001562180-21-004150 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:19 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,168 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-21-004128 · primarydocument.xml · derivative · entry 8 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,732 Underlying: Common Stock · 3,168 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:19 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,951 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001562180-21-004128 · primarydocument.xml · derivative · entry 7 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,951 shares Expires 2027-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 13, 2018 and vests as to an additional 2.083% of the shares per month thereafter until February 28, 2021. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:19 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 7,610 | $55.05 | $418,917.56 |
DisclosureSEC source: 0001562180-21-004128 · primarydocument.xml · nonDerivative · entry 3 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,589 F2 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $55.00 to $55.11. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:19 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionCommon Stock | 3,168 | $23.12 | $73,244.16 |
DisclosureSEC source: 0001562180-21-004128 · primarydocument.xml · nonDerivative · entry 2 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:19 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionCommon Stock | 1,951 | $8.16 | $15,920.16 |
DisclosureSEC source: 0001562180-21-004128 · primarydocument.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| June 02, 2021 Filed Jun 2, 2021 16:11 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,500 | $49.47 | $123,678.00 |
DisclosureSEC source: 0001562180-21-003922 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,925 F4 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $49.305 to $49.71. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 105,179 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 02, 2021 Filed Jun 2, 2021 16:11 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,500 | $48.96 | $122,407.00 |
DisclosureSEC source: 0001562180-21-003922 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,425 F4 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $48.30 to $49.29. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 105,179 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 16:09 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 226 | $48.32 | $10,919.89 |
DisclosureSEC source: 0001562180-21-003919 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,389 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.00 to $48.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 22,370 restricted stock units. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 16:11 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,854 | $48.32 | $186,217.96 |
DisclosureSEC source: 0001562180-21-003922 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,925 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.00 to $48.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 105,179 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:10 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 153 | $48.32 | $7,392.67 |
DisclosureSEC source: 0001562180-21-003921 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,136 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.00 to $48.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 13,765 restricted stock units. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:10 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 243 | $48.32 | $11,741.30 |
DisclosureSEC source: 0001562180-21-003920 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,733 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.00 to $48.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 17,716 restricted stock units. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:09 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $51.00 | $85,017.00 |
DisclosureSEC source: 0001562180-21-003918 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,951 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 10,581 restricted stock units. Read SEC document |
| May 25, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 11,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 9 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,634 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. Read SEC document |
| May 25, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 136,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 8 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 475,070 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 25, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 213,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 7 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 745,180 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 19, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 11,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 6 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,398 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. Read SEC document |
| May 19, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 136,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 611,330 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 19, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 213,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 4 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 958,920 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 13, 2021 Filed May 17, 2021 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,399 | $47.26 | $66,116.88 |
DisclosureSEC source: 0001562180-21-003494 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,779 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $47.10 to $47.34. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 13, 2021 Filed May 17, 2021 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,730 | $46.43 | $80,316.81 |
DisclosureSEC source: 0001562180-21-003494 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,178 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.97. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 13, 2021 Filed May 17, 2021 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,871 | $45.46 | $85,057.34 |
DisclosureSEC source: 0001562180-21-003494 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,908 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.985. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 13, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 11,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 3 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,161 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. Read SEC document |
| May 13, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 136,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 2 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 747,590 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 13, 2021 Filed Jul 6, 2021 21:17 UTC |
CRANDELL KEITHDirector
|
OtherCommon Stock | 213,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089485 · tm2121524-2_4seq1.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,172,660 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F1 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 11, 2021 Filed May 13, 2021 17:32 UTC |
Stetson ShawnInterim CFO and Treasurer
|
GrantStock Options (Right to buy) · Derivative | 3,321 | $0.00 Strike: $49.20 | $0.00 |
DisclosureSEC source: 0001562180-21-003464 · primarydocument.xml · derivative · entry 2 Stetson Shawn · CIK 0001862161 · Interim CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321 Underlying: Common Stock · 3,321 shares Expires 2031-05-11 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 11, 2022, and the remaining 75% vests in 36 equal monthly installments at the end of each month beginning on May 31, 2022. Read SEC document |
| May 11, 2021 Filed May 13, 2021 17:32 UTC |
Stetson ShawnInterim CFO and Treasurer
|
GrantCommon Stock | 1,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003464 · primarydocument.xml · nonDerivative · entry 1 Stetson Shawn · CIK 0001862161 · Interim CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,712 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 11, 2022, and the remaining 75% vest in 36 equal monthly installments at the end of each month beginning on May 31, 2022. F2 · balance_after: Includes 3,644 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 8 | $61.36 | $490.88 |
DisclosureSEC source: 0001562180-21-003284 · primarydocument.xml · nonDerivative · entry 4 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,615 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F3 · balance_after: Includes 23,070 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 13 | $59.01 | $767.17 |
DisclosureSEC source: 0001562180-21-003284 · primarydocument.xml · nonDerivative · entry 3 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,623 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $57.67 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 23,070 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 86 | $58.16 | $5,001.68 |
DisclosureSEC source: 0001562180-21-003284 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,636 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.75 to $59.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 23,070 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 110 | $57.25 | $6,297.18 |
DisclosureSEC source: 0001562180-21-003284 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,722 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.67 to $57.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 23,070 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 28 | $61.36 | $1,718.08 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 9 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,779 F8 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 48 | $59.01 | $2,832.62 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 8 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,807 F8 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F11 · price: This transaction was executed in multiple trades at prices ranging from $57.67 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 313 | $58.16 | $18,203.80 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 7 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,855 F8 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F10 · price: This transaction was executed in multiple trades at prices ranging from $58.75 to $59.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 400 | $57.25 | $22,898.84 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 6 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,168 F8 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F9 · price: This transaction was executed in multiple trades at prices ranging from $56.67 to $57.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 100 | $61.26 | $6,125.80 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,568 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $61.10 to $61.26. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 700 | $60.58 | $42,407.68 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,668 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $60.03 to $60.98. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 500 | $59.16 | $29,580.05 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,368 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $58.95 to $59.51. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,051 | $58.42 | $61,395.64 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,868 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $57.94 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,649 | $57.30 | $151,789.55 |
DisclosureSEC source: 0001562180-21-003287 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972,919 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.93 to $57.78. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 113,114 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 5 | $61.36 | $306.80 |
DisclosureSEC source: 0001562180-21-003286 · primarydocument.xml · nonDerivative · entry 4 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,289 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F3 · balance_after: Includes 14,237 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 9 | $59.01 | $531.12 |
DisclosureSEC source: 0001562180-21-003286 · primarydocument.xml · nonDerivative · entry 3 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,294 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $57.67 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,237 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 58 | $58.16 | $3,373.23 |
DisclosureSEC source: 0001562180-21-003286 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,303 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.75 to $59.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,237 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 75 | $57.25 | $4,293.53 |
DisclosureSEC source: 0001562180-21-003286 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,361 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.67 to $57.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,237 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 8 | $61.36 | $490.88 |
DisclosureSEC source: 0001562180-21-003285 · primarydocument.xml · nonDerivative · entry 4 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,976 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F3 · balance_after: Includes 18,466 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.